All Cases
4 cases · 4 approved / sustained · 0 denied / dismissed · 0 remanded
Others
Research and Development · Poland
WeGreened EB-2 (NIW) rfe approved
161 days 2025-05-01
The petitioner proposes to continue developing blood-based and digital biomarker diagnostics for complex mental illnesses such as schizophrenia and bipolar disorder. This work utilizes machine learning and cutting-edge analytics to probe immune system behavior for earlier diagnosis and treatment personalization.
Postdoctoral Researcher
Biotechnology · Poland
WeGreened EB-2 (NIW) approved
California 489 days 2025-04-22
The petitioner proposes to develop synthetic antibodies with enhanced functional activity against infectious agents, specifically focusing on antibody engineering strategies for conditions like HIV. This work aims to create potent, long-acting solutions for disease prevention and treatment to lower transmission rates and healthcare burdens.
Scientist
Biotechnology · Poland
WeGreened EB-2 (NIW) approved
North Carolina 12 days 2025-01-22
The petitioner proposes to continue research on engineering microorganisms for the biomanufacturing of valuable chemicals and pharmaceutical ingredients. This work focuses on establishing cost-effective domestic supply chains for essential compounds within the U.S. biotechnology sector.
Others
Biotechnology · Poland
WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.